4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
4D Molecular Therapeutics was founded in 2013 by David Kirn, David Schaffer, Theresa Janke.
1282 health care and life sciences companies are in the directory, 165 of them in the same 101-250 employee range and 43 based in San Francisco Bay Area.
4D Molecular Therapeutics experienced a mixed financial performance in 2023, missing earnings expectations. Additionally, an officer sold shares worth $49,900. Despite these setbacks, the company's stock moved 11.1% higher. The company also made significant progress in its gene therapy for severe wet AMD patients, reducing the need for anti-VEGF injections.
“4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions.” 4dmoleculartherapeutics.com
4D Molecular Therapeutics is a biotechnology company based in San Francisco Bay Area, with 101-250 employees, founded in 2013. Its founders are David Kirn, David Schaffer and Theresa Janke and it has raised $595 million over 6 rounds.
501-1,000 employees · 23andme.com
51-100 employees · abeonatherapeutics.com
251-500 employees · actgenomics.com
1-10 employees · afingen.tech
11-50 employees · adm-labs.com
11-50 employees · actx.com
11-50 employees · acernatec.com
101-250 employees · adicetbio.com
101-250 employees · aveooncology.com
101-250 employees · activemotif.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.